RECENT FEATURE ARTICLES
Coronavirus testing: a commercial view and post-analytical response
Against the ever-changing landscape of SARS-CoV-2 testing and an emerging need for sample storage, Mark Reed and Charlotte Duncan from Pro-Lab discuss a solution currently being adopted across the UK.
Blood coagulation: what’s new from the UK NEQAS BC scheme?
As a result of current restrictions, this year’s UK NEQAS BC annual scientific and scheme participants’ meeting was cancelled. Here, Ian Jennings, Dianne Kitchen and Anna Lowe are able to use Pathology in Practice to report.
Interleukin-7 and its effects: a brief look in the literature
Recent press coverage of COVID-19 disease has highlighted a possible role for interleukin-7 in boosting T-cell numbers and aiding recovery. However, the current literature reports on a wide range of other benefits of this important cytokine.
How can RFID technology and flexible electronics help pathology?
With the NHS currently under huge strain, additional time-consuming and burdensome processes add to an already heavy workload. Gillian Ewers examines the advantages that radio frequency identification offers in tracking samples and consumables.
Back at the coalface: a clinical virologist and the COVID emergency
Response to the current coronavirus pandemic has seen many retired personnel return to the clinical laboratory bench to help facilitate realisation of testing targets. Such altruistic action does reintroduce the returnee to the reality of change.
Microbiology testing networks: are they of value and fit for purpose?
Valerie Bevan looks at how microbiology testing networks have changed over the past 80 years, and how reflecting on this, and lessons from the current pandemic, might inform our response to future epidemics/pandemics.
Histologists and molecular biology: meet the next generation
One of the two recognised early pathology disciplines, histopathology now combines modern practical laboratory techniques with sophisticated molecular biology methods,both of which facilitate the application of personalised medicine.
Plasma viscosity in COVID-19 disease: a vital monitoring role.
Establishing the diagnostic and prognostic value of measuring plasma viscosity in patients suspected or confirmed as having COVID-19 is currently underway in several UK hospitals. This article provides an overview of progress in research and practice
Fusobacterium infection: is Lemiérre’s disease the tip of an iceberg?
Is Fusobacterium necrophorum an underrated anaerobic pathogen, and could Lemiérre’s disease be prevented by earlier treatment of sore throat? Here, Mike Wren looks at the available evidence and illustrates some of the issues in two short case studies
Reducing parasitic disease in Africa: multinational research
Cutting-edge flow cytometry is underpinning a pioneering multinational research initiative designed to transform the lives of those suffering from leishmaniasis, a disfiguring and potentially life-threatening parasitic disease.
Pandemic coronavirus: an overview of SARS-CoV-2 and COVID-19 disease
Pathology faces a major challenge to detect the new coronavirus, and to provide laboratory support to COVID-19 patients. Sarah Pitt provides an overview of the virology, epidemiology and laboratory diagnosis of this latest agent of disease.
Antimicrobial efficacy and lack of resistance to silane quaternary com
Does the ‘entourage effect’ explain the increase in antimicrobial efficacy and lack of resistance seen with fifth-generation silane quaternary compounds? Here, Andrew Kemp provides an overview of the development and use of such agents.
Automated algorithms for FVIII and FIX: inhibitor detection in haemophilia
The detection and monitoring of haemophilia remains a challenging process for laboratories; however, the introduction of testing algorithms is set to improve the quality and consistency of results while freeing staff time.
Coagulation profiler: proof-of-concept testing and development
Benson Viscometers is developing a novel device that can determine the clotting profile of a blood sample. Furthermore, the company also aims to develop the point-of-care capabilities of this device.
Artificial intelligence and digital pathology: a look to the future
As the pathologist workforce shrinks and workload increases, laboratory medicine is beginning to adopt advanced technology and robust AI solutions. Nathan Buchbinder and Scott Rayburn explain how digital solutions can change practice in pathology and the life sciences.
Group B Streptococcus: what are we missing in the newborn period?
Group B Streptococcus is the most common cause of severe infection in newborn babies in the UK. Despite a risk-based prevention strategy for early-onset infection, in place since 2002, rates have increased significantly.
Disinfectants and hand sanitisers: a new test of efficacy against viruses
Do hand sanitisers really work against viruses? Andrew Kemp and colleagues introduce a new methodology for testing the efficacy of disinfectants and sanitisers on surfaces and on the skin against viral isolates.
Total bile acids testing: fifth-generation method in cholestasis of pregnancy
The advanced enzyme cycling method for bile acids offers increased sensitivity and precision when compared to traditional enzymatic tests, as illustrated by its use in obstetric cholestasis diagnosis and monitoring.
Veterinary pathology in Kenya: charismatic and not so charismatic creatures
In terms of scope and geography, veterinary pathology in the field is an activity of wide horizons. In this review of a visit to Kenya, Margaret and John Cooper describe how they are committed to training the next generation of veterinary workers in East Africa.
Surgical site infections: a need to galvanise efforts to reduce occurrence
Surgical site infection continues to be a major source of concern to patients and the multidisciplinary teams involved in surgery. Sadly, however, evidence-based practice to reduce such infections is often slow to be implemented, as Kate Woodhead explains.
Featured Supplier
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. We have one mission: to do now what patients need next.
Twenty nine medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them...
Upcoming Events
Point of Care: Innovations
The Bristol - Harbourside (Doyle Collection) hotel
20 September 2022
Arab Lab Live 2022
Dubai International Convention & Exhibition Centre Dubai World Trade Centre - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates
24 - 26 October 2022
Lab Innovations 2022
Hall 2 NEC, Birmingham
2 & 3 November 2022
MEDICA 2022
Messe Düsseldorf D-40474 Düsseldorf, Stockumer Kirchstraße 61
14 - 17 November 2022
Meeting demand: the changing picture of diagnostics
The King's Fund, London, W1G 0AN
16 November 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
